編號
C8-040
徵稿主題
Prognosis Survival and Treatment Related Complications
題目
ALBI score可預測晚期膽道癌患者接受 Durvalumab 免疫化學治療的預後
作者群
藍淇禎1,
黃文冠1,4,
吳儁峰2,
吳宗翰2,
林咸舫2,
郭玹志3,
吳教恩3,
古崇顥1,
陳仁熙1,
謝佳訓1,4,
周文其1,4
服務單位
1 Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
2 Department of Hematology and Oncology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan
3 Department of Hematology and Oncology, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan
4 College of Medicine, Chang Gung University, Taoyuan, Taiwan
